These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36078156)

  • 21. AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.
    Franich NR; Fitzsimons HL; Fong DM; Klugmann M; During MJ; Young D
    Mol Ther; 2008 May; 16(5):947-56. PubMed ID: 18388917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient and Precise Processing of the Optimized Primary Artificial MicroRNA in a Huntingtin-Lowering Adeno-Associated Viral Gene Therapy
    Wang W; Zhou P; Wang X; Chen F; Christensen E; Thompson J; Ren X; Kells A; Stanek L; Carter T; Hou J; Sah DWY
    Hum Gene Ther; 2022 Jan; 33(1-2):37-60. PubMed ID: 34806402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
    McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
    Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease models.
    Morelli KH; Wu Q; Gosztyla ML; Liu H; Yao M; Zhang C; Chen J; Marina RJ; Lee K; Jones KL; Huang MY; Li A; Smith-Geater C; Thompson LM; Duan W; Yeo GW
    Nat Neurosci; 2023 Jan; 26(1):27-38. PubMed ID: 36510111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity.
    Pan Y; Zhu Y; Yang W; Tycksen E; Liu S; Palucki J; Zhu L; Sasaki Y; Sharma MK; Kim AH; Zhang B; Yano H
    J Biol Chem; 2018 Jul; 293(30):11850-11866. PubMed ID: 29891550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration.
    Nguyen MA; Karunakaran D; Geoffrion M; Cheng HS; Tandoc K; Perisic Matic L; Hedin U; Maegdefessel L; Fish JE; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):49-63. PubMed ID: 28882869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor skill learning modulates striatal extracellular vesicles' content in a mouse model of Huntington's disease.
    Solana-Balaguer J; Garcia-Segura P; Campoy-Campos G; Chicote-González A; Fernández-Irigoyen J; Santamaría E; Pérez-Navarro E; Masana M; Alberch J; Malagelada C
    Cell Commun Signal; 2024 Jun; 22(1):321. PubMed ID: 38863004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.
    Dar GH; Mendes CC; Kuan WL; Speciale AA; Conceição M; Görgens A; Uliyakina I; Lobo MJ; Lim WF; El Andaloussi S; Mäger I; Roberts TC; Barker RA; Goberdhan DCI; Wilson C; Wood MJA
    Nat Commun; 2021 Nov; 12(1):6666. PubMed ID: 34795295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease.
    Stanek LM; Sardi SP; Mastis B; Richards AR; Treleaven CM; Taksir T; Misra K; Cheng SH; Shihabuddin LS
    Hum Gene Ther; 2014 May; 25(5):461-74. PubMed ID: 24484067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice.
    Dufour BD; Smith CA; Clark RL; Walker TR; McBride JL
    Mol Ther; 2014 Apr; 22(4):797-810. PubMed ID: 24390280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huntington's Disease Protein Huntingtin Associates with its own mRNA.
    Culver BP; DeClercq J; Dolgalev I; Yu MS; Ma B; Heguy A; Tanese N
    J Huntingtons Dis; 2016; 5(1):39-51. PubMed ID: 26891106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin.
    Olson SD; Kambal A; Pollock K; Mitchell GM; Stewart H; Kalomoiris S; Cary W; Nacey C; Pepper K; Nolta JA
    Mol Cell Neurosci; 2012 Mar; 49(3):271-81. PubMed ID: 22198539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular vesicles improve GABAergic transmission in Huntington's disease iPSC-derived neurons.
    Beatriz M; Rodrigues RJ; Vilaça R; Egas C; Pinheiro PS; Daley GQ; Schlaeger TM; Raimundo N; Rego AC; Lopes C
    Theranostics; 2023; 13(11):3707-3724. PubMed ID: 37441602
    [No Abstract]   [Full Text] [Related]  

  • 36. AAV5-miHTT gene therapy for Huntington disease: lowering both huntingtins.
    Evers MM; Konstantinova P
    Expert Opin Biol Ther; 2020 Oct; 20(10):1121-1124. PubMed ID: 32658606
    [No Abstract]   [Full Text] [Related]  

  • 37. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
    Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
    J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the Mutant CAG Expansion in Huntingtin mRNA Interfere with Exonucleolytic Cleavage of its First Exon?
    Liu W; Pfister EL; Kennington LA; Chase KO; Mueller C; DiFiglia M; Aronin N
    J Huntingtons Dis; 2016; 5(1):33-8. PubMed ID: 27003665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Fresh Look at Huntingtin mRNA Processing in Huntington's Disease.
    Romo L; Mohn ES; Aronin N
    J Huntingtons Dis; 2018; 7(2):101-108. PubMed ID: 29865084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of mutant and total huntingtin expression in Huntington's disease murine models.
    Fodale V; Pintauro R; Daldin M; Altobelli R; Spiezia MC; Bisbocci M; Macdonald D; Bresciani A
    Sci Rep; 2020 Dec; 10(1):22137. PubMed ID: 33335120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.